TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/19/24 17:23 | 7/18/24 | FTRE | Fortrea Holdings Inc. | Health | Health | Medical Laboratories | Neupert Peter M | NC | D | M.d | 0 | 0.00 | 0 | 6 | 29 | 28 | D | ||||||||||||||||
3/13/24 17:55 | 3/12/24 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Neupert Peter M | WA | D | M.d | 13 | 0.8400 | 0 | 15 | 10 | 169 | D | |||||||||||||||
2/8/24 12:49 | 2/7/24 | LH | Laboratory Corp of America Holdings | DE | Health | Health | Medical Laboratories | Neupert Peter M | NC | D | M.d | 0 | 0.00 | 0 | 1 | 9 | 12 | D | |||||||||||||||
12/15/23 16:21 | 12/13/23 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Neupert Peter M | WA | D | M.d | 84 | 0.8400 | 0 | 100 | 435 | 123 | D | |||||||||||||||
8/23/23 21:12 | 8/23/23 | FTRE | Fortrea Holdings Inc. | Health | Health | Medical Laboratories | Neupert Peter M | NC | D | P | 278 | 25.30 | 0 | 11 | 100 | 22 | D | ||||||||||||||||
2/14/23 15:14 | 2/11/23 | LH | Laboratory Corp of America Holdings | DE | Health | Health | Medical Laboratories | Neupert Peter M | NC | D | M.d | 0 | 0.00 | 0 | 1 | 7 | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |